Live tape
Top 8, mentions 7d11,416NVDA4,591 mentions▲ +0.08GOOGL1,594 mentions▲ +0.03META1,283 mentions▲ +0.05NKE1,062 mentions+0.01MRVL863 mentions▲ +0.08GPRO708 mentions▲ +0.07SNDK664 mentions▲ +0.08QQQ651 mentions▲ +0.07

Equity · Healthcare

DGX

Quest Diagnostics Incorporated · NYSE

$240 −1.23% 1D Finazon · prior-day close · Aug 31, 2026

Reddit mentioned DGX 12 times in the 30 days to 1 September 2026, across 5 of the communities we track. All of them were scored for sentiment: 83% read bullish, 8% bearish and 9% neither. Reddit data updated 1 September 2026.

Price · Chart
Our own end-of-day closes 62 sessions
$260 $180 3 Jun 31 Aug

The line runs $193.79 on 3 June through $240 on 31 August, on a scale from $180 to $260. Days the market did not trade hold the previous close, flat.

The chart above plots the price of DGX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $193.79 on 3 June 2026 through $240 on 31 August 2026.

Market cap $26.5B
P/E (TTM) 24.7
52-week range $173 – $245.03
Avg volume 148.9K
Mentions · 30d 12
Net sentiment +0.11

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 1, 2026

DGX · crowd attention × price

Share ↗
12 mentions

Day27 Aug 2026

MENTIONS20–3 / day
PRICE$244.60$230–$250Source: Finazon
DGX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day0123usd$230$235$240$245$2503 Aug10 Aug18 Aug25 Aug1 Sep
DGX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.3 Aug18 Aug1 Sep
The Distributed Sentinel 01 Sep 2026

DGX's busiest day for Reddit mentions sat one session from its highest close of the window — 2 mentions on 27 August, $245.03 on 26 August

This chart in words

The chart plots daily Reddit mentions of DGX over the 30 days to 1 September 2026: 12 in total, busiest on 27 August with 2, and 2 on the last day counted. Across this window the close ran between $232 on 3 August and $245.03 on 26 August. The line is the daily close over the same window: $232 on 3 August, $240 on 31 August. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Finazon · prior-day close, most closes dollar-rounded at the source

Crowd sentiment on DGX · 30d

n = 12 scored · Method
DGX

83% bullish

Overall market sentiment

57% bullish

DGX reads 26 points more bullish than overall market sentiment. Same measure; same 30-day window.

Where DGX is discussed

(30d)
r/wallstreetbets 50% 6 +0.14
r/investing 25% 3 +0.15
r/stocks 8% 1 +0.04
r/ausfinance 8% 1 +0.08
r/asx_bets 8% 1 −0.05

Moves with DGX

co-mention r · 31 obs

Tickers whose daily Reddit volume rose and fell with DGX's. Co-discussion, not price.

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations) · Method

DGX insider trades

SEC Form 4 · last 90 days · newest reported trade 28 Aug 2026
Open-market buys 0
Open-market sells 3
Net sold $7.52M
Non-trade filings 11
Date Insider Type Shares Value
28 Aug 2026 PREVOZNIK MICHAEL E SVP & General Counsel Sell 22,677 $5.51M
28 Jul 2026 DELANEY MARK E SVP & Chief Commercial Officer Sell 1,600 $376K
04 Jun 2026 KUPPUSAMY KARTHIK SVP, Clinical Solutions Sell 8,147 $1.63M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
28 Aug 2026 PREVOZNIK MICHAEL E SVP & General Counsel Option exercise 22,677 $2.54M
28 Aug 2026 PREVOZNIK MICHAEL E SVP & General Counsel Gift 1,000
22 Jul 2026 CARTER ROBERT B Director Other 11 $2K
22 Jul 2026 DELANEY MARK E SVP & Chief Commercial Officer Other 34 $7K
22 Jul 2026 Gregg Vicky B Director Award 72 $15K
22 Jul 2026 KUPPUSAMY KARTHIK SVP, Clinical Solutions Other 37 $8K
22 Jul 2026 Lassiter Wright III Director Other 6 $1K
22 Jul 2026 MAIN TIMOTHY L Director Other 21 $4K
22 Jul 2026 Plewman Patrick SVP for Diagnostic Services Other 46 $10K
22 Jul 2026 SAMAD SAM Executive Vice President & CFO Award 102 $21K
04 Jun 2026 KUPPUSAMY KARTHIK SVP, Clinical Solutions Option exercise 8,147 $1.01M

DGX reported financials

SEC EDGAR XBRL

DGX reported revenue of $11.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was $992.0M.

Figure Reported Period
Revenue $11.0B 31 Dec 2025 fiscal year
Net income $992.0M 31 Dec 2025 fiscal year
Diluted EPS $8.75 31 Dec 2025 fiscal year
Total assets $16.9B 30 Jun 2026 at period end
Total equity $7.5B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

DGX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $2.84 $3.04B
31 Mar 2026 Q1 2026 $2.24 $2.90B
31 Dec 2025 FY 2025 $8.75 $11.04B
30 Sep 2025 Q3 2025 $2.16 $2.82B
30 Jun 2025 Q2 2025 $2.47 $2.76B
31 Mar 2025 Q1 2025 $1.94 $2.65B
31 Dec 2024 FY 2024 $7.69 $9.87B
30 Sep 2024 Q3 2024 $1.99 $2.49B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

DGX institutional holders

SEC Form 13F

14 of the 45 institutional funds we track reported a DGX position for the quarter ended 30 Jun 2026 — a combined $175.8M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Balyasny Asset Management Added +9,402.1% shares 275,371 $58.4M
Marshall Wace Added +34.7% shares 269,760 $57.2M
Citadel Advisors Trimmed −61.6% shares 133,211 $28.2M
AQR Capital Management Held (±25%) +21.7% shares 61,196 $12.9M
Citadel Advisors Added +448.8% shares 1,072,862 $5.8M
Point72 Asset Management New position 23,380 $5.0M
Millennium Management Trimmed −77.2% shares 11,434 $2.4M
Point72 Asset Management Added +113.5% shares 326,685 $1.8M
Millennium Management Added +749.8% shares 187,285 $1.0M
D. E. Shaw & Co. Trimmed −96.7% shares 4,814 $1.0M

Showing the 10 largest of 14 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

DGX fails-to-deliver

SEC CNS data

On 07 Aug 2026, 1 shares of DGX failed to deliver (about $239).

Settlement date Shares failed Notional % of shares out
07 Aug 2026 1 $239 <0.001%
03 Aug 2026 2,118 $494K 0.002%
29 Jul 2026 20 $5K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in DGX

STOCK Act disclosures

The most recent congressional trade disclosed in DGX is a sale by Julie Johnson (house, TX), dated 30 Oct 2025.

Date Member Type Amount
30 Oct 2025 filed 05 Aug 2026 Julie Johnson house · Democrat–TX Sale $1K–$15K
24 Jul 2025 filed 13 Jan 2026 Julia Letlow house · Republican–LA Sale $1K–$15K
10 Mar 2025 filed 13 Aug 2026 Carol D. Miller house · Republican–WV Sale $15K–$50K

Source: U.S. House of Representatives financial disclosures

DGX — frequently asked questions

From live data

How often is DGX mentioned on Reddit?

DGX was mentioned 2 times in the last 7 days across the finance subreddits we track, and 12 times over the trailing 30 days.

Is Reddit bullish or bearish on DGX?

Across 12 classified DGX mentions in the last 30 days, 83% read bullish, 8% bearish and 9% neutral. Crowd sentiment is a social signal, not investment advice.

When did DGX last report earnings?

Quest Diagnostics Incorporated (DGX) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are DGX insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 3 sells by DGX insiders on the open market. A further 11 filings were grants, awards, gifts or exercises rather than open-market trades.

Who is the CEO of Quest Diagnostics Incorporated?

Steve Rusckowski leads Quest Diagnostics Incorporated (DGX) as chief executive.

What exchange is DGX listed on?

Quest Diagnostics Incorporated trades on NYSE under the ticker DGX.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.